Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01951079
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01951079
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Israel
- Registry status
- Unknown status
Technical summary
Registry record NCT01951079. Allocation not applicable; no masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2014-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy
- Condition
- Arrhythmia
- Condition
- ECG Changes
- Condition
- Hypotension
- Intervention (Drug)
- Intra-amniotic injection of DIGOXIN
- Lead sponsor
- Meir Medical Center
Record details
- Record id
cardio:ct-nct01951079- Content hash
a6802227ca2cc61af278a888afaaefa2f3bb6813b9d2a9e6ad81eb452a418cbf